Could Novavax Win U.S. Authorization for Its COVID Vaccine by May?
Three COVID-19 vaccines are already on the market in the U.S. Another could be on the way. Novavax (NASDAQ: NVAX) CEO Stanley Erck thinks his company's vaccine just might win U.S. emergency use authorization as early as May. In this Motley Fool Live video recorded on March 3, 2021, Fool.com contributors Keith Speights and Brian Orelli discuss whether this timeline is realistic.
Source Fool.com
